Karyn McFadden is currently a Senior Principal Scientist in Biologics Discovery at Amgen, where they have played a pivotal role in advancing the therapeutic antibody pipeline and optimizing antibody discovery processes. Previously, Karyn served as a Scientist and Senior Scientist at Amgen, contributing to the development of core platforms for rapid antibody discovery. Karyn's educational background includes a PhD in Biochemistry from Drexel University College of Medicine, complemented by an MS in Biology from Georgian Court University and a BS in Biology from The College of New Jersey. They also have significant experience in research, having worked at Duke University and held a Research Specialist position at Drexel University College of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices